In view of the limited evidence on therapies for this extremely rare tumor that matched the methylation class of CNS tumors with BCOR/BCORL1 fusion without a detectable fusion, we reasoned that radiation therapy was warranted given the high proliferative activity. This evidence concerns the gene BCORL1 and central nervous system neoplasm.